Last week, the New York Chapter of the Juvenile Diabetes Research Foundation hosted their annual research briefing. Many chapters around the country host similar research briefings, and I was excited to find out that our local meeting would feature Dr. Sanjoy Dutta, Director of Glucose Control Therapies within the Treatment Therapies Program.
I want to note that although there’s been a lot of controversy surrounding the addition of treatment goals to JDRF’s mission, I whole-heatedly…
Read more »
Some of you may have seen the headlines this week about JDRF and Amylin investigating a new diabetes treatment — essentially a mixture of insulin and pramlintide (brand name Symlin), two substances that are only FDA approved for entirely separate use at the moment. Interesting!
The reasoning seems highly practical: “A co-formulated therapy that harnesses the benefit of both hormones might better mimic the natural physiology of the pancreas and simplify dosing decisions.”
Also in…
Read more »
Moira McCarthy Stanford might be a new D-mom blogger, but she’s been around the block and beyond advocating for diabetes. A former National Chair of Outreach and long-time supporter of the JDRF, Moira and her daughter, Lauren, have made headlines numerous times for their work advocating for a cure.
Life hasn’t been easy for Moira and Lauren, and she says they’ve learned many things the hard way — thus Moira has some strong opinions on…
Read more »
We received a whopping 210 responses to our reader survey* about the possibility of wearing an implantable insulin pump last week: Would You, If You Could? We thought you might like to know the results, below.
ALSO: we received some additional feedback from Medtronic’s Chief Medical Officer Dr. Fran Kaufman about the development of this device, sent to us by PR Manager Karrie Hawbaker. We decided this would be more visible if published in a…
Read more »
